Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating immune complexes in sickle cell-beta zero thalassemia.

E A Donadi1, I F Carvalho, R P Falcão

  • 1Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Brasil.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of the Autoimmune Regulator Gene in the Control of MHC II Antigen-Processing and Presentation by Medullary Thymic Epithelial Cells.

HLA·2025
Same author

The role of cholinesterases in chagas disease.

Parasitology international·2022
Same author

The role of HLA-G in parasitic diseases.

HLA·2018
Same author

HFE gene polymorphism defined by sequence-based typing of the Brazilian population and a standardized nomenclature for HFE allele sequences.

HLA·2017
Same author

Gene polymorphism and HLA-G expression in patients with childhood-onset systemic lupus erythematosus: A pilot study.

HLA·2017
Same author

Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2017

Patients with sickle cell-beta zero thalassemia have higher levels of C1q-precipitable immune complexes in serum fractions. This finding suggests a potential role for immune complex deposition in the disease pathology.

Area of Science:

  • Immunology
  • Hematology
  • Biochemistry

Background:

  • Sickle cell-beta zero thalassemia is a severe form of sickle cell disease.
  • Immune complex formation and deposition are implicated in various inflammatory conditions.

Purpose of the Study:

  • To investigate the presence and levels of immune complexes in serum fractions of patients with sickle cell-beta zero thalassemia.
  • To compare these levels with healthy controls.

Main Methods:

  • Serum fractions were prepared from patients with sickle cell-beta zero thalassemia and healthy controls using polyethyleneglycol precipitation.
  • C1q-precipitable immune complexes were quantified using a specific assay.
  • Protein levels and immunoglobulins (IgG, IgA, IgM), complement components (C3, C4), and factor B were measured.

Related Experiment Videos

Main Results:

  • Serum fractions from sickle cell-beta zero thalassemia patients showed significantly higher levels of C1q-precipitable immune complexes compared to controls (216 µg/dL vs 181 µg/dL, P < 0.05).
  • Increased total protein content was also observed in the patient group's serum fractions.
  • Levels of IgG, IgA, IgM, C3, C4, and factor B remained within the normal range in the analyzed serum fractions.

Conclusions:

  • Patients with sickle cell-beta zero thalassemia exhibit elevated levels of C1q-precipitable immune complexes in specific serum fractions.
  • These findings suggest a potential role for immune complex-mediated mechanisms in the pathophysiology of sickle cell-beta zero thalassemia.
  • Further research is warranted to elucidate the specific composition and clinical significance of these immune complexes.